These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38007664)

  • 21. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.
    Cody KA; Langhough RE; Zammit MD; Clark L; Chin N; Christian BT; Betthauser TJ; Johnson SC
    Brain; 2024 Jun; 147(6):2144-2157. PubMed ID: 38667631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of
    La Joie R; Visani AV; Lesman-Segev OH; Baker SL; Edwards L; Iaccarino L; Soleimani-Meigooni DN; Mellinger T; Janabi M; Miller ZA; Perry DC; Pham J; Strom A; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Neurology; 2021 Feb; 96(5):e650-e661. PubMed ID: 33262228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
    Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum.
    Illán-Gala I; Lorca-Puls DL; Tee BL; Ezzes Z; de Leon J; Miller ZA; Rubio-Guerra S; Santos-Santos M; Gómez-Andrés D; Grinberg LT; Spina S; Kramer JH; Wauters LD; Henry ML; Boxer AL; Rosen HJ; Miller BL; Seeley WW; Mandelli ML; Gorno-Tempini ML
    Brain; 2024 Apr; 147(4):1511-1525. PubMed ID: 37988272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
    Thijssen EH; La Joie R; Strom A; Fonseca C; Iaccarino L; Wolf A; Spina S; Allen IE; Cobigo Y; Heuer H; VandeVrede L; Proctor NK; Lago AL; Baker S; Sivasankaran R; Kieloch A; Kinhikar A; Yu L; Valentin MA; Jeromin A; Zetterberg H; Hansson O; Mattsson-Carlgren N; Graham D; Blennow K; Kramer JH; Grinberg LT; Seeley WW; Rosen H; Boeve BF; Miller BL; Teunissen CE; Rabinovici GD; Rojas JC; Dage JL; Boxer AL;
    Lancet Neurol; 2021 Sep; 20(9):739-752. PubMed ID: 34418401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia.
    Josephs KA; Duffy JR; Strand EA; Machulda MM; Senjem ML; Lowe VJ; Jack CR; Whitwell JL
    Alzheimers Dement; 2014 Nov; 10(6):630-6. PubMed ID: 24985533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival Analysis in Primary Progressive Apraxia of Speech and Agrammatic Aphasia.
    Whitwell JL; Martin P; Duffy JR; Clark HM; Utianski RL; Botha H; Machulda MM; Strand EA; Josephs KA
    Neurol Clin Pract; 2021 Jun; 11(3):249-255. PubMed ID: 34484892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type.
    Lagarde J; Olivieri P; Tonietto M; Gervais P; Comtat C; Caillé F; Bottlaender M; Sarazin M
    Transl Psychiatry; 2021 Sep; 11(1):498. PubMed ID: 34588422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study.
    Ismail R; Parbo P; Madsen LS; Hansen AK; Hansen KV; Schaldemose JL; Kjeldsen PL; Stokholm MG; Gottrup H; Eskildsen SF; Brooks DJ
    J Neuroinflammation; 2020 May; 17(1):151. PubMed ID: 32375809
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Tsai RM; Bejanin A; Lesman-Segev O; LaJoie R; Visani A; Bourakova V; O'Neil JP; Janabi M; Baker S; Lee SE; Perry DC; Bajorek L; Karydas A; Spina S; Grinberg LT; Seeley WW; Ramos EM; Coppola G; Gorno-Tempini ML; Miller BL; Rosen HJ; Jagust W; Boxer AL; Rabinovici GD
    Alzheimers Res Ther; 2019 Jan; 11(1):13. PubMed ID: 30704514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau uptake in agrammatic primary progressive aphasia with and without apraxia of speech.
    Utianski RL; Whitwell JL; Schwarz CG; Duffy JR; Botha H; Clark HM; Machulda MM; Senjem ML; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Eur J Neurol; 2018 Nov; 25(11):1352-1357. PubMed ID: 29935044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.
    Meyer PF; Pichet Binette A; Gonneaud J; Breitner JCS; Villeneuve S
    JAMA Neurol; 2020 Apr; 77(4):508-516. PubMed ID: 31961372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of in vivo retention of [
    Freiburghaus T; Pawlik D; Oliveira Hauer K; Ossenkoppele R; Strandberg O; Leuzy A; Rittmo J; Tremblay C; Serrano GE; Pontecorvo MJ; Beach TG; Smith R; Hansson O
    Acta Neuropathol; 2024 Sep; 148(1):44. PubMed ID: 39297933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apraxia of speech and phonological errors in the diagnosis of nonfluent/agrammatic and logopenic variants of primary progressive aphasia.
    Croot K; Ballard K; Leyton CE; Hodges JR
    J Speech Lang Hear Res; 2012 Oct; 55(5):S1562-72. PubMed ID: 23033449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer's Disease.
    Senda M; Ishii K; Ito K; Ikeuchi T; Matsuda H; Iwatsubo T; Iwata A; Ihara R; Suzuki K; Kasuga K; Ikari Y; Niimi Y; Arai H; Tamaoka A; Arahata Y; Itoh Y; Tachibana H; Ichimiya Y; Washizuka S; Odawara T; Ishii K; Ono K; Yokota T; Nakanishi A; Matsubara E; Mori H; Shimada H
    J Prev Alzheimers Dis; 2021; 8(4):495-502. PubMed ID: 34585225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
    Tanner JA; Iaccarino L; Edwards L; Asken BM; Gorno-Tempini ML; Kramer JH; Pham J; Perry DC; Possin K; Malpetti M; Mellinger T; Miller BL; Miller Z; Mundada NS; Rosen HJ; Soleimani-Meigooni DN; Strom A; La Joie R; Rabinovici GD
    Brain; 2022 Dec; 145(12):4489-4505. PubMed ID: 35762829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
    Li WW; Shen YY; Tian DY; Bu XL; Zeng F; Liu YH; Chen Y; Yao XQ; Li HY; Chen DW; Zhou FY; Yang H; Li QM; Bao WQ; Guan YH; Zhou HD; Jin RB; Wang YJ
    J Alzheimers Dis; 2019; 69(1):169-178. PubMed ID: 30958377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech.
    Whitwell JL; Weigand SD; Duffy JR; Strand EA; Machulda MM; Senjem ML; Gunter JL; Lowe VJ; Jack CR; Josephs KA
    Neuroimage Clin; 2016; 11():90-98. PubMed ID: 26937376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.